International Medical Conference

Endometriosis 2024:
Elevating Sampson’s Century Legacy via
Deep Dive with AI

For the benefit of Endometriosis Foundation of America (EndoFound)

May 2-3, 2024 - JAY CENTER (Paris Room) - NYC

109 West 39th Street, New York, NY 10018

Add event to calendar

AppleGoogleOffice 365OutlookOutlook.comYahoo



The 15th annual EndoFound Medical Conference will focus on the relevance of Sampson's many contributions to endometriosis care and research today. Sampson's "intelligent treatment of patients," research, and search for "knowledge"  embody vital components of EndoFound's mission to educate the next generation of medical professionals. This cornerstone event convenes top clinicians and researchers globally in NYC annually, fostering collaborative discussions to brainstorm care strategies. Not only does the conference delve into cutting-edge AI and technology advancements in endometriosis research, but it also champions the collaborative spirit of the medical community. By intertwining Sampson's enduring legacy with contemporary breakthroughs, the conference underscores an unwavering commitment to shaping the future of endometriosis care through education, collaboration, and innovation.

Note(*): Sampson had about 8 to 12 theories and 30 or more observations that are relevant today. Those include,

  • John Sampson built on the shoulders of Rokitansky, Pick, Bell, Bailey, Cullen, Novak, and others. 1925b
  • Sampson did not say implanted endometrium was endometriosis. Endometriosis differs from endometrium "both in structure and in function." 1921 
  • Ectopic endometrial glands and stroma is not a reasonable definition. Ectopic implanted endometrium is a precursor to endometriosis.  Sampson "could trace the transition of one type of lesion into the other.” 1927a
  • The implantation theory does not account for all instances of ectopic endometrium-like tissue in the pelvis.”  “Menstruation is only one means of disseminating that tissue.” 1927a
  • He published both retrograde dissemination and venous dissemination in 1927. 1927a & 1927b
  • The "intelligent treatment of patients who have peritoneal endometriosis" is more important than whether the source of endometriosis was "metaplasia of the surface epithelium of the ovary," "congenitally misplaced epithelium," or "the implantation theory." 1940
SCIENTIFIC DIRECTOR
  • Dan Martin, MD., Scientific & Medical Director, Endometriosis Foundation of America (EndoFound)
PROGRAM DIRECTOR
  • Tamer Seckin, MD., co-founder of Endometriosis Foundation of America (EndoFound)

Sponsorship Opportunities 

Medical Conference 2024

Previous EndoFound Conferences